Federal marijuana rescheduling will not impact South Dakota medical program

Summarised from 2 outlets · Updated 15 Oct, 13:32 · Archive

South Dakota's medical marijuana program will continue operating under federal rescheduling of the drug to Schedule III.

South Dakota Attorney General Marty Jackley has issued an official opinion confirming that the federal rescheduling of marijuana to Schedule III will not impact the state's medical cannabis programme. Federal law explicitly permits state medical-marijuana programmes to operate, meaning South Dakota's programme can continue as it currently does.

The DEA has established a pathway allowing participants in state medical marijuana programmes to register with the federal government and continue operating. State Senator John Carley, vice chairman of the legislative Medical Marijuana Oversight Committee, requested the opinion.

Jackley noted that any future changes to the programme would be decided at the state level, either by the South Dakota Legislature or by voters.

How it is being reported

• What federal marijuana rescheduling means for South Dakota’s medical marijuana programSouth Dakota AG Marty Jackley issued an opinion confirming that federal rescheduling of marijuana to Schedule III will not impact the state’s medical cannabis program.Dakotanewsnow · 15 Oct, 02:00
• AG: Rescheduling won't impact S.D. medical marijuanaSIOUX FALLS, S.D. (KELO) -- The federal decision to reschedule marijuana as a Schedule III controlled substance will not impact South Dakota’s Medical Marijuana program, according to the South Dakota Attorney General's office. In a news release, Attorney General Marty Jackley gave an official opinion. “Because federal law explicitly permits state medical-marijuana programs, South Dakota’s [...]Keloland · 13 Oct, 20:15

In this story: South Dakota · Marty Jackley · United States

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem